Detalhe da pesquisa
1.
Very early versus early referral for ablation in young patients with newly diagnosed paroxysmal atrial fibrillation.
Pacing Clin Electrophysiol
; 45(3): 348-356, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150152
2.
Site-specific cancer risk following cobalt exposure via orthopedic implants or in occupational settings: A systematic review and meta-analysis.
Regul Toxicol Pharmacol
; 129: 105096, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896478
3.
Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies.
Regul Toxicol Pharmacol
; 125: 104987, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34229014
4.
A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices.
Regul Toxicol Pharmacol
; 123: 104932, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872739
5.
An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union.
Regul Toxicol Pharmacol
; 125: 105004, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256083
6.
Carcinogenic hazard assessment of cobalt-containing alloys in medical devices: Review of in vivo studies.
Regul Toxicol Pharmacol
; 122: 104910, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662479
7.
Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study.
BMC Cardiovasc Disord
; 20(1): 161, 2020 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32252637
8.
Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation.
JACC Clin Electrophysiol
; 6(6): 636-645, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553212
9.
Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.
Circulation
; 107(8): 1141-5, 2003 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12615792
10.
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
J Am Coll Cardiol
; 43(7): 1211-6, 2004 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-15063432
11.
Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
Am Heart J
; 146(3): 489-93, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12947368
12.
Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
Am Heart J
; 143(4): 643-9, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11923801
13.
Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
J Clin Pharmacol
; 42(4): 388-94, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11936563
14.
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
J Am Coll Cardiol
; 48(3): 471-7, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16875971
15.
Azimilide for atrial fibrillation: clinical trial results and implications.
Card Electrophysiol Rev
; 7(3): 215-9, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14739716